Log in to save to my catalogue

Exploiting innate immunity for cancer immunotherapy

Exploiting innate immunity for cancer immunotherapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2511b2e1dbb841e1a6a4f281545a4c1e

Exploiting innate immunity for cancer immunotherapy

About this item

Full title

Exploiting innate immunity for cancer immunotherapy

Publisher

England: BioMed Central Ltd

Journal title

Molecular cancer, 2023-11, Vol.22 (1), p.187-187, Article 187

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Immunotherapies have revolutionized the treatment paradigms of various types of cancers. However, most of these immunomodulatory strategies focus on harnessing adaptive immunity, mainly by inhibiting immunosuppressive signaling with immune checkpoint blockade, or enhancing immunostimulatory signaling with bispecific T cell engager and chimeric anti...

Alternative Titles

Full title

Exploiting innate immunity for cancer immunotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2511b2e1dbb841e1a6a4f281545a4c1e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2511b2e1dbb841e1a6a4f281545a4c1e

Other Identifiers

ISSN

1476-4598

E-ISSN

1476-4598

DOI

10.1186/s12943-023-01885-w

How to access this item